Avadel Pharmaceuticals Announces Journal of Urology Publication of Phase 3 Data on NOCTIVA
DUBLIN, Ireland, Sept. 28, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on providing innovative medicines for chronic urological, central nervous system, and sleep disorders, announced today that the Journal of …